What is CBD (Cannabidiol)?

CBD (Cannabidiol) is a non-psychoactive chemical compound found in cannabis plants, representing one of over 100 identified cannabinoids. Unlike THC (tetrahydrocannabinol), CBD does not produce the intoxicating "high" associated with cannabis consumption, making it an attractive option for consumers seeking potential therapeutic benefits without impairment. CBD was first isolated in 1940 by American chemist Roger Adams and its structure was fully elucidated in 1963 by Israeli researcher Raphael Mechoulam. The compound interacts with the body's endocannabinoid system, particularly CB1 and CB2 receptors, though its mechanisms are still being studied. The 2018 Farm Bill legalized hemp-derived CBD products containing less than 0.3% THC at the federal level, creating a multi-billion dollar market. According to industry reports, the U.S. CBD market was valued at approximately $4.9 billion in 2022 and is projected to reach $16.8 billion by 2025. CBD is available in various forms including oils, tinctures, capsules, topicals, edibles, and vape products. Hemp-derived CBD products are widely available, while cannabis-derived CBD products remain subject to state-specific regulations. Concentrations typically range from 250mg to 3,000mg per product. The FDA has approved one CBD-based prescription medication, Epidiolex, for treating specific forms of epilepsy. However, the FDA has not approved CBD for other health claims, and consumers should consult healthcare providers before use. Quality varies significantly across products, with third-party lab testing recommended to verify potency and purity. *This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals before using CBD products.*